Meltem Uyanik1, Michael Abern2, Brandon Caldwell2, Muge Karaman3, Winnie Mar4, Virgilia Macias5, Xiaohong Joe Zhou1,3,4,6, and Richard Magin7
1Richard and Loan Hill Department of Bioengineering, University of Illinois at Chicago, Chicago, IL, United States, 2Urology, University of Illinois at Chicago, Chicago, IL, United States, 3Center for Magnetic Resonance Research, College of Medicine, University of Illinois at Chicago, Chicago, IL, United States, 4Radiology, University of Illinois at Chicago, Chicago, IL, United States, 5Pathology, University of Illinois at Chicago, Cahicago, IL, United States, 6Neurosurgery, University of Illinois at Chicago, Chicago, IL, United States, 7Richard and Loan Hill Department of Bioengineering, University of Illinois, Chicago, IL, United States
Synopsis
Prostate cancer is a common malignancy among men. Using MRI to
discriminating high-grade disease from benign and indolent cancer in the
prostate is highly desirable for treatment planning. Single and multi-
exponential models of diffusion signal decay in the prostate has proven useful
for determining prostate cancer tissue structure. However, classification of
cancer grade remains illusive. In this study, we investigate the stretched
exponential signal decay model using histology and ROC analysis to determine if
it will more accurately characterize aggressive prostate cancer.
Introduction
Prostate cancer is one of
the most common malignancy among men in the US [9]. Diffusion-weighted MRI
(DWI) plays an important role in providing important biological information on
regional changes in prostate tissue. The
most commonly used method for DWI is a single exponential signal decay to
generate a spatial map of the apparent diffusion coefficient (ADC, mm2/s).
DWI studies of the prostate showed the usefulness of single exponential signal
decay on noninvasively determining human tissue structure [4],[8],[10]. However,
diffusion weighted signal decay in the prostate does not follow a single
exponential pattern and therefore, it is inadequate to differentiate between
benign prostate inflammation and hyperplasia [3]. To overcome this problem,
Bennett et al. [1] introduced the stretched exponential model. It has been
shown that the stretched exponential signal decay model parameters provide more
information about tumor than ADC [5-7]. In this study, we show the ability of
using a stretched exponential model to establish the correspondence between the
DDC and α -maps with histological sections of
the entire prostate gland to characterize aggressiveness
of prostate cancer.
Methods
Patients. This study enrolled a total of 10 patients with
high-grade proven prostate cancer. Imaging. (a) MR Protocol. Patients
were scanned on a 3T multi-parametric MRI (GE Healthcare, Discovery 750 MRI), Figure
1a, prior to radical prostatectomy (RP). DWI images (TR 2500 ms, TE 68 ms, FOV
28x28 cm2, matrix 256x256, resolution 1.09 mm) were acquired at
multiple b-values (50, 500, 1000, 1500, and 2000 s/mm2) with the
corresponding averages (2, 4, 8, 12, and 16). The slice thickness was 3 mm for
all sequences. (b) Histology Protocol. Whole embedded RP sections were
digitized at 20X magnification using a digital scanner (Scanscope CS, Aperio
Technologies), and all tumor foci were annotated (Aperio ImageScope 11.2.0.780,
Leica Biosystems) by Gleason pattern (Figure 1b) by a board certified
genitourinary pathologist. A zonal scheme was devised for matching the MRI to
the RP sections based on the orientation to the urethra (anterior/posterior,
left/right, level from base to apex). Model
fitting. The multi-b-value diffusion data were fitted to the
mono-exponential model. using the following equation: $$S = S_0 e^{(-b\times
ADC)}.$$ To quantify the degree of tissue heterogeneity, the multi-b-value
diffusion data were fitted to the stretched exponential model, [1] using the
following equation: $$S = S_0 e^{[-(b \times DDC)^\alpha ]},$$ where DDC (mm2/s)
is the distributed diffusion coefficient , and α (0 < α < 1) is a
heterogeneity index that characterizes the multi-exponential nature of
diffusion-related signal decay [2]. The data was fit pixel by pixel for
selected slices to the mono-exponential and to the stretched-exponential models
using a nonlinear least squares fitting algorithm in Matlab (MathWorks). Statistical
Analysis. Fifty-two (52) target quadrant regions were identified as healthy
or unhealthy from one patient. The
performance of the stretched exponential model for differentiating between
benign prostate inflammation and hyperplasia was evaluated and compared with the
mono-exponential model using a receiver operating characteristic (ROC)
analysis. ROIs were drawn by using the means of each quadrants of ADC, DDC, and
α.
Multivariate
logistic regression was used to combine the stretched exponential model
parameters (DDC, and α). All statistical
analyses were carried out using Matlab (MathWorks).
Results
Figure 2 shows a whole
prostate ADC, DDC, and α
maps from a representative patient. Figure 3a shows the group analysis as
presented in the boxplots of the mean ADC,
DDC, and α. Figure 3b shows the corresponding descriptive statistics, exhibiting
sample mean and standard deviation, (±σ), of ADC,
DDC, and α for healthy and unhealthy. All parameters show
significant differences (p-values<0.05)
between healthy and unhealthy. Figure 4 shows the ROC results for the
ADC, DDC, α,
and combined (DDC,α) parameters. The ROC of combined (DDC,α)
parameters yielded the highest
sensitivity (0.857), and area under the curve (AUC = 0.874).Discussion and Conclusion
ADC maps are sensitive to regional
changes in prostate tissue, however, their diagnostic specificity is not enough
for distinguishing between benign prostate inflammation and hyperplasia [3]. The
results showed that the stretched-exponential model with multi-b values
diffusion data has potential in establishing the correspondence between the DDC
and α -maps with histological sections of the entire prostate
gland. The ROC analysis showed that the combination of the stretched exponential
model parameters is more accurate of differentiating high grade prostate cancer from benign
and indolent prostate cancer.Acknowledgements
This research was supported by Department of Defense
PRTA W81XWH-15-1-0346 (Abern).References
[1] Kevin M Bennett et
al. Characterization of continuously distributed cortical water diffusion rates
with a stretched-exponential model. Magnetic resonance in medicine,
50(4):727–734, 2003.
[2] MN Berberan-Santos et
al. Mathematical functions for the analysis of luminescence decays with
underlying distributions 1. kohlrausch decay function (stretched exponential).
Chemical Physics, 315(1):171–182, 2005.
[3] Jonathan
I Epstein et al. Upgrading and downgrading of prostate cancer from biopsy to
radical prostatectomy: incidence and predictive factors using the modified
gleason grading system and factoring in tertiary grades. European urology,
61(5):1019–1024, 2012.
[4] Kazuhiro
Kitajima, Yasushi Kaj et al. Prostate cancer detection with 3 t mri: Comparison
of diffusion-weighted imaging and dynamic contrast-enhanced mri in combination
with t2-weighted imaging. Journal of Magnetic Resonance Imaging, 31(3):625–631,
2010.
[5] Thomas
C Kwee et al. Intravoxel water diffusion heterogeneity imaging of human
high-grade gliomas. NMR in biomedicine, 23(2):179–187, 2010.
[6] Xiaohang
Liu et al. Comparison of stretched-exponential and mo- noexponential model
diffusion-weighted imaging in prostate cancer and normal tissues. Journal of
Magnetic Resonance Imaging, 42(4):1078–1085, 2015.
[7] Yousef
Mazaheri et al. Diffusion-weighted magnetic resonance imaging of the prostate:
improved robustness with stretched exponential modeling. Journal of computer
assisted tomography, 36(6):695–703, 2012.
[8] Rajakumar
Nagarajan et al. Correlation of gleason scores with diffusion-weighted imaging
findings of prostate cancer. Advances in urology, 2012, 2011.
[9] Lindsey
A Torre et al. Jemal. Global cancer statistics, 2012. CA: a cancer journal for
clinicians, 65(2):87–108, 2015.
[10] Bashar Zelhof et al. Correlation of diffusion-weighted magnetic resonance
data with cellularity in prostate cancer. BJU international, 103(7):883–888,
2009.